Northrop Grumman Corporation
NYSE:NOCAerospace & Defense
-$32.91 today
- Market cap
- $77.14B
- Beta
- -0.12
- P/E (TTM)
- 16.1
- EPS (TTM)
- $32.20
- Dividend yield
- 1.82%
Volume 0.86M
Average 0.86M
NOC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Northrop Grumman CorporationNYSE: NOC
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $306M (cash outflow) rose 1.7% year over year, ahead of the -10.4% change in trailing-twelve-month capital expenditures. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +0.3% a year.
Context
- Capital expenditures amounted to 3.5% of revenue in FY2025, down 0.9 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1.7% holds above the trailing-twelve-month pace of -10.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.45B) USD
- Year-over-year change
- +17.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.45B) | +17.9% |
| FY2024 | 2024-12-31 | (1.77B) | +0.5% |
| FY2023 | 2023-12-31 | (1.78B) | -23.7% |
| FY2022 | 2022-12-31 | (1.44B) | -1.4% |
| FY2021 | 2021-12-31 | (1.42B) | — |
Capital Expenditures vs competitors
How NOC compares with its peers on the latest reported figures
- NOC's LTM Sep 2026 capital expenditures of $1.44B is the 5th largest of the 7 companies compared; the peer median is $1.63B.
- Its year-over-year change of -10.4% is the lowest of 7, against a peer median of +52.1%.
- Capital expenditures amounts to 3.3% of revenue for NOC, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.85B | +63.1% | +34.0% | 4.1% | |
| LTM Sep 2026 | $3.31B | +7.6% | +4.0% | 3.4% | |
| LTM Sep 2026 | $1.73B | -2.1% | -0.4% | 2.2% | |
| LTM Oct 2026 | $1.53B | +68.4% | +1.4% | 2.7% | |
| LTM Sep 2026 | $1.44B | -10.4% | +0.3% | 3.3% | |
| LTM Jul 2026 | $484M | +41.1% | +18.9% | 2.1% | |
| LTM Jun 2026 | $29M | +125.9% | +12.3% | 0.2% | |
| Peer median (excluding NOC) | $1.63B | +52.1% | +8.1% | 2.4% | |
Competitors are the stored peer set for NOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.01B | 4.9B | 2.06B | 4.17B | 4.18B |
| Depreciation & Amortization | 1.24B | 1.34B | 1.34B | 1.37B | 1.47B |
| Deferred Income Tax | 603M | (321M) | (988M) | (582M) | 548M |
| Stock-Based Compensation | 94M | 99M | 87M | 101M | 119M |
| Change in Working Capital | 181M | (600M) | (144M) | 335M | (863M) |
| Accounts Receivables | (10M) | (44M) | 54M | (33M) | (108M) |
| Inventory | (52M) | (205M) | (220M) | (358M) | 97M |
| Accounts Payables | 376M | 572M | 519M | (513M) | 646M |
| Other Working Capital | (133M) | (923M) | (497M) | 1.24B | (1.5B) |
| Other Non-Cash Items | (5.56B) | (2.52B) | 1.53B | (1.01B) | (701M) |
| Operating Cash Flow | 3.57B | 2.9B | 3.88B | 4.39B | 4.76B |
| Capital Expenditures | (1.42B) | (1.44B) | (1.78B) | (1.77B) | (1.45B) |
| Acquisitions (Net) | 3.4B | 155M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 197M | 0 | 0 |
| Other Investing Activities | 73M | 39M | (4M) | 18M | 295M |
| Investing Cash Flow | 2.06B | (1.24B) | (1.58B) | (1.75B) | (1.16B) |
| Debt Repayment | (2.24B) | 0 | 945M | 2.5B | (502M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (3.71B) | (1.5B) | (1.5B) | (2.51B) | (1.62B) |
| Dividends Paid | (983M) | (1.05B) | (1.12B) | (1.19B) | (1.29B) |
| Other Financing Activities | (78M) | (57M) | (90M) | (190M) | (133M) |
| Financing Cash Flow | (7B) | (2.61B) | (1.76B) | (1.4B) | (3.55B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.38B) | (953M) | 532M | 1.24B | 50M |
| Free Cash Flow | 2.15B | 1.47B | 2.1B | 2.62B | 3.31B |
Northrop Grumman Corporation
NYSE:NOC
Intrinsic Alpha fair value
Locked
Current Price
$542.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.